Mr. Perceval Gaillard draws the attention of the Minister of Health and Access to Care to the need to make the chikungunya vaccine refundable in Reunion. (Photo photo RB/www.imazpress.com)
According to the Pasteur Institute, chikungunya is a viral disease transmitted to humans by the bite of Aedes albopictus and Aedes aegypti mosquitoes. This disease can cause significant pain and prolonged disability, affecting the quality of life of those affected. In certain cases, joint signs can last for a few weeks to several years, even longer if the patient’s age is advanced. Currently in France, 80% of departments have conditions conducive to the emergence of the disease.
In 2005, Reunion Island experienced a health crisis of unprecedented scale. 165,000 people were affected by the chikungunya epidemic in Reunion and 40,000 in Mayotte, or around 30% of the population. In February 2006, at the height of the crisis, the number of new weekly cases was estimated at 45,000.
For several weeks, the ARS of Reunion has been warning of the emergence of a new epidemic which is fueled by three large active outbreaks, in Hermitage, Étang-Salé and Grand-Bassin.
After the green light from the European Union, the first vaccine against chikungunya has been available since November 20, in French pharmacies and also in Reunion Island: XCHIQ. Prescribed on medical prescription, it costs 150 euros and a single dose provides protection for 3 years.
However, this vaccine is not yet reimbursed by Health Insurance. The ARS of Reunion having initiated a procedure in this direction, discussions are underway between the High Health Authority and social security, particularly regarding the target audience.
The MP insists on the importance of prompt decision-making to make the chikungunya vaccine refundable by Health Insurance to the inhabitants of Reunion. We must act as quickly as possible given the current situation which is deteriorating day by day.
Perceval Gaillard, Tribune libre, Chikungunya
